Description
CAGRILINTIDE 5MG
5MG | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
Cagrilintide 5mg is an experimental peptide acting as a long-acting amylin analogue. Within experimental protocols, this molecule is studied for its role in satiety control and its synergistic potential when combined with GLP-1 receptor agonists for the regulation of energy metabolism. Explore our full range of Research Peptides.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | Cagrilintide 5mg |
| Sequence | {Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 |
| Molecular Formula | C194H312N54O59S2 |
| Molecular Weight | 4409.01 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 5 mg per vial |
| Grade | Laboratory Research Grade |
Research Application Areas
- Amylin Receptor Agonism: Study of the modulation of satiety signals within the central nervous system.
- Gastric Emptying Delay: Research on the impact of digestive kinetics on postprandial glucose absorption.
- Metabolic Synergy: Analysis of the combined effect with incretins (GLP-1/GIP) on the reduction of caloric intake.
- Glucose Homeostasis: Study of the suppression of postprandial glucagon secretion.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
